advertisement

Topcon

Acta Ophthalmologica Scandinavica 9

Showing records 1 to 9 | Display all abstracts in Acta Ophthalmologica Scandinavica

18920 Metabolic abnormalities in patients with primary open-angle glaucoma
Elisaf M; Kitsos G; Bairaktari E; Kalaitzidis R; Kalogeropoulos C; Psilas K
Acta Ophthalmologica Scandinavica 2001; 79: 129-132
18933 Delivering a diagnosis of glaucoma: are we considering the patient or only his eyes?
Anders H
Acta Ophthalmologica Scandinavica 2001; 79: 107
18934 The impact of glaucoma on the quality of life of patients in Norway. II. Patient response correlated to objective data
Odberg T; Jakobsen JE; Hultgren SJ; Halseide R
Acta Ophthalmologica Scandinavica 2001; 79: 121-124
18935 The impact of glaucoma on the quality of life of patients in Norway. I. Results from a self-administered questionnaire
Odberg T; Jakobsen JE; Hultgren SJ; Halseide R
Acta Ophthalmologica Scandinavica 2001; 79: 116-120
18976 Clinical comparison of the measurement of the IOP with the ocular blood flow tonometer, the Tonopen XL and the Goldmann applanation tonometer
Bafa M; Lambrinakis I; Dayan M; Birch M
Acta Ophthalmologica Scandinavica 2001; 79: 15-18
19044 Functional and structural measurements in a multifactorial glaucoma risk model
Polo V; Abecia E; Pablo LE; Pinilla I; Larrosa JM; Honrubia FM
Acta Ophthalmologica Scandinavica 2001; 79: 10-14
19064 Exfoliation (pseudoexfoliation) syndrome: toward a new understanding. Proceedings of the First International Think Tank
Ritch R; Schloetzer-Schrehardt U
Acta Ophthalmologica Scandinavica 2001; 79: 213-217
19094 Consumption of glaucoma medication
Calissendorff BM
Acta Ophthalmologica Scandinavica 2001; 79: 2-5
19116 Latanoprost versus combined therapy with timolol plus dorzolamide: IOP-lowering effect in open-angle glaucoma
Polo V; Larrosa JM; Gomez ML; Pablo LE; Honrubia FM
Acta Ophthalmologica Scandinavica 2001; 79: 6-9

Issue 3-1

Change Issue


advertisement

Oculus